Introduction
============

Chondral damage due to trauma or pathologic changes commonly leads to cartilage degeneration and osteoarthritis development, eventually resulting in total joint degradation. The restoration of articular cartilage defects is clinically challenging because its highly organized layered structure and avascularity hamper recovery [@B1], [@B2]. It is suggested that appropriate intervention in the early stages could postpone progressive destruction in articular cartilage diseases. However, generally, joint cartilage deterioration is difficult to effectively verify and treat as it requires precise imaging technologies and noninvasive inspection [@B3], [@B4]. In the past several decades, magnetic resonance imaging (MRI) has been widely employed in clinical joint injury diagnosis and plays an indispensable role in noninvasive chondral damage detection through multidirectional scanning and 3D reconstruction. Even though significant improvements have been developed, such as higher field intensity, sensitive coils and advanced pulse sequences, it is still not possible to properly distinguish the subtle cartilage structure [@B3] and the artifacts caused by partial volume effects during the precise cartilage defect inspection [@B5], [@B6]. Paramagnetic or superparamagnetic nanoparticles (MNPs), such as gadopentetate dimeglumine (Ga-DTPA) [@B7], copper sulphide (CuS) [@B8] and ferroferric oxide (Fe~3~O~4~) [@B9], could be used as MR contrast agents. Some of them can even integrate multi-mode imaging technologies, and are reliably used in deep-tissue imaging [@B10].

Superparamagnetic Fe~3~O~4~ MNPs have been intensively developed for use in some areas, such as magnetic sensors [@B11], storage media [@B12], medical applications [@B13] and anti-infection nanozyme [@B14]. Notably, Fe~3~O~4~ is regarded as a biocompatible drug carrier, and has been approved by the FDA in both clinical research and treatment. Currently, modified Fe~3~O~4~ MNPs are used as drug vehicles [@B13], MRI agents [@B15], and tracers [@B16]*in vitro* or*in vivo*, where they usually influence transverse relaxation and act as negative contrast agents [@B17]. Even though Fe~3~O~4~ offers various benefits, it is still sensitive to magnetization and oxidation [@B18], therefore a superficial coating is essential for protection and stability.

To improve tissue regeneration, composite materials have been used in tissue engineering, such as strontium-graphene oxide (Sr-GO) nanocomposites [@B19]. However, they are usually resistant to breakdown in the human body. Chitosan is a natural polysaccharide and has attracted extensive interest because of its reasonable cost, biodegradability and biocompatibility. Conjugating a macromolecular skeleton onto MNPs contributes to electronic stability as well as pharmacodynamics and relaxivity [@B20], [@B21]. In addition, the deacetylated products of chitosan are rich in exposed amino groups, providing potential reactive sites and preventing metal sedimentation by charge repulsion. Preparation made by chemically coupling chitosan tends to improve solubility, accelerates cellular penetration and internalization, and even changes the targeting sites [@B22]. Thus, chitosan is a promising macromolecule for coating the core of metal oxides.

As an aromatic and drug-like compound, kartogenin (KGN) was initially screened out as a growth factor contributing to chondrogenesis and chondroprotection that works in a dose-dependent manner [@B23]. In the presence of KGN, filamin A is known to disrupt the interaction with the core-binding factor β subunit (CBFβ), leading to stimulation of mesenchymal stem cells (MSCs) and chondrogenesis [@B2], [@B23], [@B24]. Unlike the readily degradable bio-macromolecular growth factors, KGN is reasonably chemically stable in solution. In addition, this cytokine cocktail enables a reduction of nitric oxide (NO) and free glycosaminoglycans (GAGs) on inflamed and damaged chondrocytes [@B23], [@B24].

Recently, great achievements have been realized in the area of magnetic iron oxide nanoparticles for noninvasive *in vivo* diagnosis. In the clinic, Gd and Fe are usually employed as basic elements for contrast agents in different MRI scanning patterns. Gd chelators are used as positive T~1~-weighted contrast agents due to a decrease in the spin-lattice relaxation time [@B25]. Mn is another element for MR imaging, which can be used as a T~1~-weighted contrast agent [@B26]. However, some drawbacks still need to be addressed, such as renal toxicity and tissue accumulation [@B17], [@B27]. Fe, as an intrinsic element of the human body, has been approved by the FDA for clinical application. Differing from Gd chelates, Fe contrast agents display superparamagnetism and usually provide dark T~2~-weighted imaging. In some case, Fe^2+^ ions from Fe agents gradually transform into Fe^3+^, resulting in positive and brighter images [@B28].

Based on the above rationale, we designed a novel magnetic Fe~3~O~4~ nanoprobe for joint cartilage with distinctively enhanced brighter T~2~-weighted contrast effects. In this study, oleic acid-modified ferroferric oxide (Fe~3~O~4~ oleic acid) was further grafted with positive-charge bearing chitosan (Fe~3~O~4~-CS), which then self-aggregated by the interplay between it and negatively charged KGN, and by hydrophobic interactions, causing its assembly into larger superparamagnetic nanoparticles (Fe~3~O~4~-CS/KGN). These superparamagnetic nanoparticles exhibited brighter T~2~-weighted enhancement *in vitro* and *in vivo*, due to an enclosed Fe~3~O~4~ core and KGN causing ferric electric charge transfer. Furthermore, Fe~3~O~4~-CS/KGN was also verified as an effective medical carrier that stimulated adipose tissue-derived stem cells (ADSCs) to increase type 2 collagen (Col Ⅱ) secretion and chondrogenic differentiation. This carrier was proven susceptible to elimination *in vivo*, since the enhanced bright ferroferric oxide signals were hardly detectable after 12 weeks. Additionally, Fe~3~O~4~-CS/KGN also played a protective and restorative role in cartilage regeneration, leading to lesion restoration in osteochondral lesions. This study describes the mechanism of Fe~3~O~4~ self-assembly formation as well as a distinctly brighter T~2~-weighted imaging, which strongly suggests the potential application of the magnetic probes in diagnosis and regeneration of cartilage.

Results and Discussion
======================

Characterization of Fe~3~O~4~-CS/KGN nanoparticles
--------------------------------------------------

The Fe~3~O~4~-CS/KGN MNPs were synthesized via modification of a condensation reaction and self-assembly. As shown in Figure [1](#F1){ref-type="fig"}, the original Fe~3~O~4~ oleic acid MNPs were successfully grafted with chitosan via EDC/sulfo-HOSu, leading to an increase in diameter from 10 nm to 10-20 nm (Figure [1](#F1){ref-type="fig"}A and [1](#F1){ref-type="fig"}B). As shown by transmission electron microscopy (TEM, Tecnai G2 Spirit BioTwin, USA) images, Fe~3~O~4~ was encapsulated with a thick CS shell, which prevented the Fe~3~O~4~ from aggregating. In order to load KGN into Fe~3~O~4~ MNPs, the monomer Fe~3~O~4~-CS particles were aggregated to form larger assembled Fe~3~O~4~-CS/KGN MNPs ([Figure S1](#SM0){ref-type="supplementary-material"}, confirmed by nuclear magnetic resonance, NMR, Avance Ⅲ, 600 MHz, Bruker, Germany), which had a general diameter of 102 ± 12 nm [@B29] (Figure [1](#F1){ref-type="fig"}C and F). In order to explore the spectroscopic characteristics of the material, UV-Vis and Fourier transform infrared (FT-IR) spectroscopy were employed. As shown in Figure [1](#F1){ref-type="fig"}D, Fe~3~O~4~-oleic acid and Fe~3~O~4~-CS had no apparent absorbance peaks, while the self-assembled Fe~3~O~4~-CS/KGN had a strong, broad absorbance peak at approximately 283 nm, indicating that KGN was attached to the Fe~3~O~4~-CS nanoparticles and induced Fe~3~O~4~-CS to grow into larger Fe~3~O~4~-CS/KGN nanoparticles. In the FT-IR spectrum (Figure [1](#F1){ref-type="fig"}E), the peaks between 2924 cm^-1^ and 2973 cm^-1^ were present in Fe~3~O~4~-CS as well as in Fe~3~O~4~-CS/KGN, while CS showed weak, broad peaks in the same positions. Additionally, several strong peaks in the region 1700-500 cm^-1^ were observed, indicating that KGN was loaded into Fe~3~O~4~-CS/KGN MNPs. The loading amount was calculated to be 32% according to the standard KGN curve.

In addition, the behavior of KGN release was also explored ([Figure S2](#SM0){ref-type="supplementary-material"}). In the first 6 hours, KGN was slightly released from Fe~3~O~4~-CS/KGN at both pH5.5 and pH7.4. Over the next 2 days, the free KGN gradually increased, and the cumulative amount of released KGN at pH 5.5 was more than that at pH 7.4.

The possible reasons for KGN-induced self-assembly are as follows: Firstly, CS is a positively charged polymer that promotes tissue penetration [@B30]. Conversely, KGN is an organic molecule that bears negative charges due to the carboxyl residue. In this way, the amino group interacts with the carboxyl residue on KGN, causing their intimate integration, this could result in hydrogen bond formation [@B31]. Another factor may be the structural rigidity of KGN, which is inclined to hydrophobically interact with the alkane chains of CS. Therefore, monodispersed Fe~3~O~4~-CS nanoparticles aggregate via combination with KGN molecules.

The T~2~-weighted contrast agent of Fe~3~O~4~-CS/KGN *in vitro*
---------------------------------------------------------------

As shown in Figure [2](#F2){ref-type="fig"}A, with increasing Fe concentrations, the T~2~-weighted MRI contrast effect was significantly enhanced in low field NMR (LF-NMR, MesoMR23-060H-I, China). Of note, the signal became brighter with increasing concentrations. For further quantification, the gray value of each concentration was calculated. It was found that the MR signals became brighter with the increasing Fe concentrations. In order to investigate the T~2~ relaxation, several concentrations of Fe, from Fe~3~O~4~-CS/KGN, were employed to fit the curve (1/T~2~ against Fe concentrations), and the *r~2~* value was calculated as 66.59 mM^-1^s^-1^ according to the slope of the corresponding fitting line (Figure [2](#F2){ref-type="fig"}B). At the molecular level of magnetic resonance, the T~2~ contrast enhancement principle of superparamagnetic Fe~3~O~4~ is explained by the outer sphere model. In general, T~2~ relaxation is dominated by native superparamagnetism, and it is also related to the protonic effective diffusion in the outer sphere [@B17], [@B32]. For Fe~3~O~4~-CS/ KGN nanoparticles, CS was grafted on the surface of Fe~3~O~4~-oleic acid and there was a thick polymer shell formation, which encapsulated the metal core and limited random water movement. Thus, the protons from H~2~O were expelled from the Fe~3~O~4~ cores. Furthermore, the charges of carboxyl groups on KGN easily occupied empty orbitals from the Fe~3~O~4~. Additionally, the aryl skeleton of KGN enabled the inner water proton to remain out of the sphere core, which in turn intensified the hydrophobicity and enhanced the T~2~-weighted imaging.

The biocompatibility and cellular uptake of Fe~3~O~4~-CS/KGN *in vitro*
-----------------------------------------------------------------------

To validate the biocompatibility of Fe~3~O~4~-CS/ KGN nanoparticles *in vitro*, CCK-8 assays were applied to investigate the cell viability. Firstly, as shown in [Figure S3](#SM0){ref-type="supplementary-material"}, we extracted the ADSCs and examined the differentiation antigens of ADSC characterization, such as CD90, CD44 and CD11b. The CCK-8 assay results revealed that neither Fe~3~O~4~-CS/ KGN nor KGN exhibited a significant cellular toxicity in ADSCs. As shown in Figure [2](#F2){ref-type="fig"}C, even high concentrations of Fe~3~O~4~-CS/KGN MNPs at 10 μM had a negligible inhibitory effect at 24 h. Incubation of Fe~3~O~4~-CS/KGN at different concentrations of 10 μM, 1 μM and 100 nM with ADSCs were all biocompatible. In addition, an Annexin/PI apoptosis kit was employed by flow cytometry (FCM, BD FACS Calibur system, USA), and the result also showed the negligible cytotoxicity *in vitro*. As shown in [Figure S4](#SM0){ref-type="supplementary-material"}, few apoptotic cells were found in corresponding quadrants. The calcein-AM/PI staining ([Figure S5](#SM0){ref-type="supplementary-material"}, observed by laser scanning confocal microscope, LSCM, TCS SP8, Leica, Germany) also indicated that few PI marked red cells were captured, suggesting high cellular viability. All the experimental results indicated good biocompatibility of Fe~3~O~4~-CS/KGN MNPs *in vitro*.

In order to verify the higher efficiency of cellular uptake, 6, 12 and 24 h LSCM observations were conducted with 20 μg/mL calcein or Fe~3~O~4~-CS/ calcein [@B33]. In Figure [2](#F2){ref-type="fig"}D and [2](#F2){ref-type="fig"}E, after 6 h incubation, calcein treatment resulted in a higher fluorescence signal, but only slight intracellular fluorescence was detected when cells were incubated with Fe~3~O~4~-CS/ calcein. The relative fluorescent quantification ratio was approximately 4:2; at 12 h, the fluorescence intensity of the Fe~3~O~4~-CS/calcein group increased, while it was still weaker than that of calcein, and the ratio of fluorescence intensity further increased to 8:3. However, at 24 h, the ratio of fluorescence intensity of calcein and Fe~3~O~4~-CS/calcein reversed to 24:38. Eventually, free calcein was released from Fe~3~O~4~-CS/ calcein, and the fluorescence intensity was greater compared with the other groups, suggesting that the self-assembly increased cellular internalization. Once internalized in the lysosome, the free drug was gradually liberated from the assembled nanoparticles at a low pH [@B33].

The intercellular distribution of Fe~3~O~4~-CS/KGN MNPs and stimulating differentiation potential
-------------------------------------------------------------------------------------------------

As depicted in Figure [3](#F3){ref-type="fig"}A, the intracellular distribution of Fe~3~O~4~-CS/KGN MNPs was visualized via TEM. After 24 h incubation, partly self-assembled MNPs and dissociated Fe~3~O~4~ particles were co-encapsulated in lysosomes, indicating that the magnetic beads were easily internalized via the clathrin-lysosome route [@B34] and subsequently degraded. Prussian Blue staining is a typical ferric dye, and \[Fe(CN)~6~\]^4-^ compound from Prussian Blue combines with Fe, leading to the formation of deposit. As shown in Figure [3](#F3){ref-type="fig"}B, Prussian Blue deposits were extensively distributed in the cytoplasm, while the cytomorphology remained unchanged.

In this study, we introduced Fe~3~O~4~-CS/KGN to mediate ADSC chondrogenesis. In a 2-week stimulating differentiation experiment, ADSCs generated type 2 collagen (Col Ⅱ) as evidenced by their immunofluorescence. We found that a greater expression level of Col Ⅱ was detected after the treatment with 10 μM Fe~3~O~4~-CS/KGN than that of the KGN group (Figure [3](#F3){ref-type="fig"}D). This result suggested that Fe~3~O~4~-CS/KGN can promote ADSCs to develop into chondrocyte-like phenotypes.

Cartilage injury is always accompanied by a damaged calcified area [@B35]. According to the knee osteochondral defect model in the calcified zone, even subchondral bone is impaired. The functions of subchondral bone are involved mechanical stress and support [@B36]. In some cases, subchondral bone deficiency may lead to superficial cartilage layer regeneration failure [@B37]. Sometimes, in different metabolic environments, osteogenesis and chondrogenesis differentiation compete with each other [@B38]. Here, we also compared the potential of affecting osteogenesis in the presence/absence of Fe~3~O~4~-CS/ KGN MNPs in an osteoblast-inducing conditioning medium over 4 weeks. As shown in Figure [3](#F3){ref-type="fig"}C, the equivalent mineralized sediments (orange sediments, Alizarin red S staining) were deposited in the extracellular matrix (ECM) both in PBS alone and Fe~3~O~4~-CS/KGN groups. Therefore, this system has an insignificant impact on the mineralization process and osteogenesis.

The potentials of including chondrogenesis and osteogenesis indicated that the Fe~3~O~4~-CS/KGN can be used to efficiently promote either hyaline cartilage formation or osteogenic maintenance. On one hand, KGN as the chondrogenic molecule, which relies on a more effective drug-delivery path, fosters chondral formation by regulating the CBFb-RUNX1 pathway to a larger extent [@B2], [@B23], [@B24]. On the other hand, this drug delivery system does not inhibit the osteogenic activity of ADSCs. KGN was reported to potentially accelerate osteogenesis via the regulation of silent information regulator type 1 (SIRT1) [@B39]. As a consequence, KGN-loaded Fe~3~O~4~ MNPs enhanced intercellular antioxidant effects and maintained osteogenic capacity. However, the mechanism of Fe~3~O~4~-CS/KGN accelerating chondrogenesis but not affecting osteogenesis remains to be clarified.

T~2~-weighted imaging using Fe~3~O~4~-CS/KGN MNPs *in vivo*
-----------------------------------------------------------

Although the biocompatibility and biosafety Fe~3~O~4~-CS/KGN MNPs were demonstrated in T~2~-weighted imaging *in vitro*, the effectiveness of the MNPs as both contrast and therapeutic agents was further investigated *in vivo*. Firstly, a rabbit model was established via forming a cartilage defect on the femoral trochlea. Figure [4](#F4){ref-type="fig"}A displays the results of a 4-week treatment in the presence/absence of Fe~3~O~4~-CS/KGN (n = 5). For the PBS group, a significant edema signal was observed via MRI (MRI, Bruker 70/20 UR, Germany), which was abnormally brighter than the surrounding tissue (blue arrow), indicating postoperative complications. Compared with the PBS treated group, the KGN-incubated ADSCs group (KGN group) did not show significant edema signals. However, the defect position was difficult to discern because of the surrounding unaffected tissue. This may be the result of favorable healing, or difficult identification due to limitation of the MR instrument. In the Fe~3~O~4~-CS/KGN group, the defect position was easily identified, and demarcation was clearly observed. The negligible edema signal may be due to KGN improving ADSCs chondrogenesis [@B23]. Its antioxidant properties [@B39] may also reduce the oxidative stress response caused by trauma or inflammation [@B40]-[@B42], thus protecting ADSCs and chondrocytes from apoptosis. On the other hand, Fe~3~O~4~-CS/KGN played a significant role in brighter T~2~-weighted MR imaging, which was a result of the increased proton transverse relaxation. The MR signals from the defect (red circle) were thus distinct from adjacent tissue and highlighted the defect boundaries. From micro-CT diagnosis (Figure [4](#F4){ref-type="fig"}B, Xradia 520 Versa, Zeiss, Germany), we found that part of the newly formed bone trabecula was mineralized underneath the cartilage, indicating that Fe~3~O~4~-CS/KGN MNPs did not suppress osteogenesis in the osteochondral defect model. However, the cartilage layer was not yet completely formed after the first 4 weeks.

After 12-weeks of restoration, the MRI results showed that the recovery was almost complete among the control, KGN alone and Fe~3~O~4~-CS/KGN groups. As shown in Figure [4](#F4){ref-type="fig"}A (12 W), the edema signals mostly disappeared, while the newly formed cartilage layer was irregular and rough. Compared with the control group, the tissue in the KGN-treated group was more organized, and newly formed bone was visible, but the newly-formed cartilage was faintly rough. As for Fe~3~O~4~-CS/KGN, from the MRI, the new cartilage layer appeared to be integrated and lubricated, and new bone trabecula was reconstituted. Additionally, the enhanced T~2~-weighted contrast signals were almost undistinguishable. Notably, the micro-CT images revealed that the subchondral bone was totally calcified and that there was a clear demarcation line between cartilage and bone (Figure [4](#F4){ref-type="fig"}B, 12 W), indicating that Fe~3~O~4~-CS/KGN did not inhibit the osteochondral reconstruction.

Throughout the 12-week period, we found that Fe~3~O~4~-CS/KGN MNPs acted as positive contrast agents in the early stage*in vivo* and then were eliminated by metabolic process in the last stage. On one hand, it was believed that Fe~3~O~4~ nanoparticles were removed via a cytoprotective mechanism, and endocytosis caused metal nanoparticles to enter the cytoplasm; however, nanoparticles were still trapped into cytoplasmic vesicles and were divided randomly [@B43], [@B44]. On the other hand, the self-assembled MNPs could be disintegrated by the low pH environment in the lysosome. These may be the reasons that the T~2~-weighted signals were reduced over the 12-week period. The results indicated that the metal nanoparticles were eliminated and that they were verified to be safe and biocompatible.

Histological assessment
-----------------------

After 4 weeks, in the PBS group, we observed severe disruption at the site of tissue regrowth accompanied by massive mononuclear cell infiltration (red arrow of Figure [5](#F5){ref-type="fig"}A, HE staining), and thus severe distinct edema. The nuclei of mononuclear cells were dyed with hematine and were distributed both in the superficial and calcified layers. KGN treatment resulted in the formation of neo-chondrocytes and the appearance of round cells. Extensive mononuclear cell infiltration was not found in the lesion (HE staining), but a new cartilaginous matrix formed at the edge of the defect (toluidine blue staining). However, the boundary between the subchondral bone and the cartilage was still obscure. In comparison, the Fe~3~O~4~-CS/KGN treatment obviously improved the outcome. The HE staining results showed that no small mononuclear cells infiltrated the femoral trochlea, and it was not observed the deterioration of surrounding cartilage due to osteochondral injury. Moreover, the subchondral plate was preliminarily formed together with isogenous chondral groups (toluidine blue). From the pathological assessment, it was possible to determine that the outermost layer was almost completely formed, and homogeneous ECM was encapsulated at the rim of the lesion. Of the above three groups, the lesion demarcation in the Fe~3~O~4~-CS/KGN group was fully integrated. In conclusion, this therapy can effectively promote cartilage formation and osteochondral regeneration. However, Safranin-O staining (Figure [6](#F6){ref-type="fig"}A) did not yet show normalization due to the lack of sufficient proteoglycans, and additional days were required for restoration.

At 12 weeks (Figure [5](#F5){ref-type="fig"}B), the three groups showed enhanced healing compared with the 4-week restoration time point. Generally, the PBS group showed a mild sign of repair, such as palingenetic tissue covering the defect, and the massive mononuclear cells disappeared. However, no tidemark or superficial fibrous structure was completely generated, and the unintegrated structure may not transmit the mechanical forces properly. KGN-bearing ADSCs could undergo chondrogenesis in the upper layer, and subchondral ossification took place in the lower cartilage zone, which had a remarkable calcified tidemark. The only drawback was that the superficial chondral layer was thin and unfilled. Nevertheless, the non-lubricated cartilage layer may induce later osteoarthritis (OA) because it cannot transmit stress heterogeneously from various directions [@B37], [@B45]. In the Fe~3~O~4~-CS/KGN group, an adequately smooth superficial layer was well- integrated with ambient ECM, and the differentiated round cells were orientated with a column arrangement in the underlying lower zone. Safranin-O staining (Figure [6](#F6){ref-type="fig"}A) showed more homogeneous proteoglycans accumulation, indicating new and intact cartilage formed.

At 12 weeks, International Cartilage Repair Society (ICRS) scores were used for the regenerative evaluation [@B2]. Significant improvements were observed in the Fe~3~O~4~-CS/KGN group (Figure [6](#F6){ref-type="fig"}B). Histological scoring evaluation was used to assess the osteochondral regeneration from six aspects, including total score, structure characteristics, integration, joint surface regularity, Safranin-O staining and subchondral morphology. As a result, the Fe~3~O~4~-CS/KGN group had generally higher scores than the other groups.

Overall, compared with the 4- and 12-week restoration results, an improved therapeutic effect was obtained, especially the Fe~3~O~4~-CS/KGN MNPs group, which exhibited an intact chondral/ subchondral structure, lubricated superficial layer and demarcated integration. It is worth mentioning that newly differentiated chondrocytes will secrete more ECM if left for several weeks. Thus, the newly formed cartilage will be closer to native tissue. However, it is still unclear how this carrier simultaneously regulates chondrogenesis and osteogenesis.

Conclusion
==========

In summary, we designed and prepared a nanoprobe consisting of chitosan covalently-coupled Fe~3~O~4~ oleic acid nanoparticles that were induced to self-assemble in the presence of negative charge- bearing KGN (Fe~3~O~4~-CS/KGN MNPs). This material showed its enhanced and bright T~2~-weighted contrast performance in MRI and improved the regeneration of osteochondral defects. Differing from simply KGN-induced chondrogenesis, this study systematically demonstrated that the positive MR contrast agent, Fe~3~O~4~-CS/KGN, not only intensified cellular uptake and dramatically strengthened Col Ⅱ secretion *in vitro*, but also improved *in vivo* MR T~2~-weighted contrast imaging of lesions. It also cooperatively enhanced the potential of KGN for inducing chondroid differentiation without exerting an inhibitory influence on subchondral formation. Furthermore, the ADSCs in combination with biocompatible Fe~3~O~4~-CS/KGN nanoprobes as catabolic materials that can be eliminated by the body. This novel magnetic carrier provides a noninvasive approach for *in vivo* diagnosis and treatment of complex joint cartilage damage.

Materials and Methods
=====================

Preparation of Fe~3~O~4~-CS/KGN MNPs
------------------------------------

To a 100 μL 10 mg/mL Fe~3~O~4~-oleic acid solution (Ocean, USA) was added 5 mL N, N-dimethylformamide (DMF), and the mixed solution was stirred at room temperature for 1 h. Then 10 mg sulfo-HOSu (Aladdin, China) and 10 mg EDC hydrochloride (Aladdin, China) were dispersed in 3 mL DMF, which was added into the above solution. Subsequently, a catalytic amount of triethylamine (TCI, Japan) was employed as an additive to activate the reaction. Over 24 h, the residues were purified by DMF and 0.1% acetic acid (Aladdin, China) under a magnetic field. The purified MNPs were re-suspended in 1% CS (Aladdin, China)/acetic acid solution and allowed to react for another 24 h to form Fe~3~O~4~-CS nanoparticles. The complex MNPs were further purified via a dialysis tube (MW = 300 KDa) for 48 h.

To obtain Fe~3~O~4~-CS/KGN self-assembly, 3 mg KGN was firstly dissolved in 0.5 mL DMSO and then was dropped into Fe~3~O~4~-CS solution, and kept stirring for 24 h. Finally, to remove extra KGN, the mixture was dialyzed against water for 48 h (MW = 3 KDa).

*In vitro* relaxation time and MRI study
----------------------------------------

To explore the property of Fe~3~O~4~-CS/KGN MNPs, the relaxation time of MNPs was assessed, and an *in vitro* MR imaging study was performed. A series of concentrations, 0.10 mM, 0.08 mM, 0.06 mM, 0.05 mM and 0 mM were used for measuring the *r~2~* value (n = 3) in a 0.5 T magnetic resonance scanner. The parameters were follows: flip angle = 90^o^, TR = 1800 ms, TE = 18.2 ms, and RG = 26 dB.

Rabbit ADSC extraction and identification
-----------------------------------------

The animal experiments were approved and in accordance with instructions of the Institute Animal Use and Care Committee of Shanghai Jiao Tong University. Rabbit ADSCs were extracted from the abdominal fat of 2.5-2.7 kg rabbits. Briefly, when the rabbits were anesthetized, the abdomen hair was removed and the skin sterilized. The extracted fat was peeled from the abdomen using sterilized surgical instruments. The fat tissue was cut into small pieces and digested in 0.1% Type 1 Collagenase (Gibco, USA) for 45 min at 37 ℃. The suspension was filtered via cell strainers (100 μm, BD, USA) to obtain filter liquid, which was centrifuged at 2000 rpm for 10 min. After discarding the supernatant, the residues were re-suspended with F-12 medium (Gibco, USA) containing 10% fetal bovine serum (FBS, Gibco, USA) and seeded in culture flasks. The complete medium was replaced every 3 days until 70-80% cell attachment was reached.

In order to characterize the extracted cellular phenotype, FCM was used to identify ADSCs. In this study, BB770-conjugated anti-CD44 (BB770-CD44), PE-conjugated anti-CD90 (PE-CD90) and APC-conjugated anti-CD11b (APC-CD11b, BD, USA) antibodies were used for phenotype identification. The procedure was performed according to the manufacturer\'s specifications. ADSCs at passage 3-5 were employed in all the *in vitro*/*vivo* experiments.

Cellular cytotoxicity and apoptosis assay
-----------------------------------------

Firstly, the viability of ADSCs after exposure to Fe~3~O~4~-CS/KGN was assessed. Briefly, ADSCs were seeded in a 96-well plate at a concentration of 3 × 10^4^ cells/mL (100 μL per well, n=5) in F12 medium with 10% FBS. After 12-h culture, the F12 complete medium was replaced with fresh medium containing 10 μM, 1 μM or 100 nM KGN or Fe~3~O~4~-CS/KGN, and PBS as a blank control. The medium was discarded after 24 h and fresh medium with 10 % CCK-8 was added. After incubating for 1-2 h, the absorbance was detected using a microplate reader at a wavelength of 450 nm.

Additionally, for the apoptosis assay, the Annexin-FITC/PI kit (Yeasen, China) was employed to investigate the cytotoxicity of Fe~3~O~4~ MNPs. Rat ADSCs were seeded in 6-well plates at a density of 1 × 10^5^ cells/mL (n=3). When the ADSC attachment reached 60-70%, F12 containing 100 nM, 1 μM or 10 μM Fe~3~O~4~-CS/KGN was added to the wells and the cells were cultured for 4 h (n=3), then the medium was replaced with chondrogenic inducing medium for 24 h. Furthermore, PBS treatment was used for a control group. Following this, ADSCs were dissociated using 0.25% trypsin-EDTA and washed three times with PBS. The procedure was performed according to the manufacturer\'s instructions. The prepared cell samples were detected via FCM within 30 min.

The experimental procedure for live/dead cell staining with Calcein-AM/PI double staining was performed following the apoptosis assay procedures listed previously, and the staining was performed according to the kit instructions (Dojindo, Japan).

Cellular internalization
------------------------

ADSCs were seeded in Ibidi dishes (Germany) at a density of 5 × 10^4^ cells/dish (n= 3). After 12h, 2 mL fresh medium with 20 μg/mL calcein or Fe~3~O~4~-CS/calcein was added to the dishes after discarding the supernatants. The cells were collected at 6 h, 12 h and 24 h, respectively. After washing with PBS 3 times, at room temperature, 4% paraformaldehyde was used to fix the cells for 10 min. Then, 1 μg/mL DAPI was used to stain the cell nuclei (2 mL) for 10 min. The prepared samples were kept in PBS and observed via LSCM [@B33].

Chondrogenic and osteogenic differentiations
--------------------------------------------

ADSCs were seeded at a density of 5 × 10^4^ cells/dish in Ibidi dishes (Germany), and cultured overnight. The supernatant was discarded and replaced with chondrogenic or osteogenic stimulating medium (Cyagen, USA) containing 10 μM KGN or Fe~3~O~4~-CS/KGN. After 4 h, both the KGN-containing medium was removed and replaced with the corresponding simulating medium for a further 48 h. After the procedure was continued for 2 weeks (chondrogenic differentiation) [@B2] or 4 weeks (osteogenic differentiation) [@B46], the anti-type 2 collagen (Novus, USA) antibody was used for chondrogenesis immunofluorescence, and Alizarin Red-S (Cyagen, USA) was used to stain the newly formed calcium nodules, indicating osteogenic differentiation.

Animal cartilage defect model
-----------------------------

To prepare for use in the animal *in vivo* experiments, ADSCs were first treated with 10 μM Fe~3~O~4~-CS/KGN MNPs or KGN for 2 weeks. Briefly, ADSCs at a density of 3 × 10^5^ cells/well were planted on the coverslips of 6-well plates. After 12 h, 10 μM Fe~3~O~4~-CS/KGN MNPs or KGN was added, the cells were further cultured for 4 h, and then the supernatant was discarded. The above procedure was repeated for 14 days, and the medium was replaced every 3 days.

The animal experiments were conducted according to the instructions of the institute Animal Use and Care Committee of Shanghai Jiao Tong University. Generally, 2.5-2.7 kg male rabbits were anesthetized using Zoletil, sterilized, and then the hair from right knees was removed. A defect (4 mm in diameter and 3 mm in depth, n = 5) was formed on the femoral trochlea by removing cartilage and sub subchondral bone. The prepared ADSCs were shaved off from coverslips via a scraper, and the collected ADSCs (appropriately 1 × 10^6^ cells) were deposited in lesions. Defects with PBS treatment were regarded as a control. Specimens in the *in vivo* animal study were evaluated at 4 and 12 weeks. The MR diagnoses were made using the guidance of professional physicians. The parameters of T~2~-weighted imaging were set as follows: Echo Spacing, 8.0 ms; Repetition Time, 2200 ms; Echo Time, 12 ms; FOV = 35 mm ×35 mm.

Statistical Analysis
--------------------

Origin 2018 was utilized in diagraph analysis and particle data analysis. *t*-testing statistical analysis was employed to evaluate the experimental data significance. Differences among groups are denoted as ns for not significant, \* for *P* \< 0.05, \*\* for *P* \< 0.01, and \*\*\* for *P* \< 0.001. The samples in each test were at least tested three times.
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ADSC

:   adipose tissue-derived stem cell

CBFβ

:   core-binding factor β subunit

Col Ⅱ

:   type 2 collagen
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:   chitosan
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DMF
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ECM

:   extracellular matrix

EDC

:   1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride

FBS

:   fetal bovine serum

FCM
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FDA

:   Food and Drug Administration

Fe~3~O~4~

:   ferroferric oxide

FT-IR

:   Fourier transform infrared
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:   glycosaminoglycans

ICP-MS

:   inductively coupled plasma-mass

ICRS

:   International Cartilage Repair Society

KGN

:   kartogenin

LSCM

:   laser scanning confocal microscope

MNP

:   magnetic nanoparticle

MRI

:   magnetic resonance imaging

MSC

:   mesenchymal stem cell

NMR

:   nuclear magnet resonance

PBS

:   phosphate buffer solution

SIRT1

:   silent information regulator type 1

sulfo-HOSu

:   sulfo-N-hydroxy succinimide

TEM

:   transmission electron microscopy

![**Characterization of Fe~3~O~4~-CS/KGN. A)**, **B)** and **C)** corresponde to the mophology of the Fe~3~O~4~ oleic acid, the Fe~3~O~4~-CS and the Fe~3~O~4~-CS /KGN nanoparticles, respectively. Scale bar is 50 µm; **D)** The UV-Vis spectra; **E)** the FT-IR spectrum; **F)** the diameter distribution of the Fe~3~O~4~-CS /KGN nanoparticles (n = 100).](thnov10p5565g001){#F1}

![**Magnetic and cellular characterization of Fe~3~O~4~-CS/KGN. A)** T~2~-weighted MR images of different Fe~3~O~4~-CS /KGN concentrations *in vitro* (Fe concentrations), \* *P* \< 0.05, \*\* *P* \< 0.01, \*\*\**P* \< 0.001, ns: not significant; **B)** 1/T~2~ against Fe concentrations; **C)** the CCK-8 cell toxicity assays in the presence of different Fe~3~O~4~-CS /KGN or KGN concentrations; **D)** confocal images of ADSCs exposed to 20 μg/mL Fe~3~O~4~-CS/calcein or free calcein at 6 h, 12 h and 24 h (all scale bars are 25 μm);**E)** fluorescence quantification of the internalization by ADSCs after 6 h, 12 h and 24 h incubation (n = 10).](thnov10p5565g002){#F2}

![**Intracellular distribution and stimulating differentiations of ADSCs. A)** the TEM images of Fe~3~O~4~-CS /KGN inside the lysosomes of ADSC (24 h); **B)** Prussian Blue staining images for the distribution of Fe~3~O~4~-CS /KGN after 24 h (scale bars is 20 µm); **C)** the osteogenic stimulating differentiation with PBS or Fe~3~O~4~-CS /KGN *in vitro* (4 weeks, Alizarin Red S staining, scale bar is 20 µm); **D)** the type 2 collagen immunofluorescent images of induced ADSCs by 10 µM KGN or Fe~3~O~4~-CS /KGN *in vitro* (2 weeks). All scale bars are 20 µm.](thnov10p5565g003){#F3}

![**MRI and micro-CT diagnose *in vivo*. A)** the T~2~-weighted MR images (red circle: defect site; blue arrow: edema signals; green arrow: newly formed cartilage); **B)** micro-CT images of rabbit knees after treatment with Fe~3~O~4~-CS /KGN (W = weeks).](thnov10p5565g004){#F4}

![**Histologic assessments. A)** and**B)** correspond to HE and Toluidine Blue staining of rebuilt osteochondral lesions after 4- and 12-week treatment (red arrow: mononuclear cells; all scale bars are 200 µm).](thnov10p5565g005){#F5}

![**A)** Safranin-O staining of rebuilt osteochondral lesions (all scale bars are 200 µm); **B)** ICRS scoring (n = 3), \* *p* \< 0.05, \*\* *p* \< 0.01, \*\*\**p* \< 0.001, ns: not significant.](thnov10p5565g006){#F6}
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